Free Trial Information
BioCentury | Nov 19, 2019
Politics & Policy

Investors sound alarm about pending drug pricing legislation

...Investments; Peter Kolchinsky, managing partner, RA Capital Management, LP; Jim Plante, managing director & founder, Thynk Capital...
Read More
BioCentury | Sep 28, 2018
Emerging Company Profile

GDF11 against aging

...Funds raised: $5.5 million Investors: Bold Capital, WTI, Stanford StartX fund, Longevity Fund, Kizoo Ventures, Thynk Capital...
Read More
BioCentury | Sep 7, 2018
Financial News

Anti-aging Elevian debuts with $5.5M seed funding

...million in seed funding from Bold Capital, WTI, Stanford StartX fund, Longevity Fund, Kizoo Ventures, Thynk Capital...
Read More
Items per page:
1 - 3 of 3
BioCentury | Nov 19, 2019
Politics & Policy

Investors sound alarm about pending drug pricing legislation

...Investments; Peter Kolchinsky, managing partner, RA Capital Management, LP; Jim Plante, managing director & founder, Thynk Capital...
Read More
BioCentury | Sep 28, 2018
Emerging Company Profile

GDF11 against aging

...Funds raised: $5.5 million Investors: Bold Capital, WTI, Stanford StartX fund, Longevity Fund, Kizoo Ventures, Thynk Capital...
Read More
BioCentury | Sep 7, 2018
Financial News

Anti-aging Elevian debuts with $5.5M seed funding

...million in seed funding from Bold Capital, WTI, Stanford StartX fund, Longevity Fund, Kizoo Ventures, Thynk Capital...
Read More
Items per page:
1 - 3 of 3